Clinical Trial Update: Erythropoietin and Iron Supplementation for Patients With Chemotherapy-induced Anaemia [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating erythropoietin with iron supplementation for managing chemotherapy-induced anemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Anemia

Drugs mentioned

• Erythropoietin (erythropoietin)
• Iron supplementation (Iron)

Snippet

Sponsor: Shanghai East Hospital | Conditions: Chemotherapy-induced Anaemia | Phase 4 | Status: UNKNOWN